Your browser doesn't support javascript.
loading
Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.
Cormier-Dequaire, Florence; Bekadar, Samir; Anheim, Mathieu; Lebbah, Said; Pelissolo, Antoine; Krack, Paul; Lacomblez, Lucette; Lhommée, Eugénie; Castrioto, Anna; Azulay, Jean-Philippe; Defebvre, Luc; Kreisler, Alexandre; Durif, Franck; Marques-Raquel, Ana; Brefel-Courbon, Christine; Grabli, David; Roze, Emmanuel; Llorca, Pierre-Michel; Ory-Magne, Fabienne; Benatru, Isabelle; Ansquer, Solene; Maltête, David; Tir, Melissa; Krystkowiak, Pierre; Tranchant, Christine; Lagha-Boukbiza, Ouhaid; Lebrun-Vignes, Bénédicte; Mangone, Graziella; Vidailhet, Marie; Charbonnier-Beaupel, Fanny; Rascol, Olivier; Lesage, Suzanne; Brice, Alexis; Tezenas du Montcel, Sophie; Corvol, Jean-Christophe.
  • Cormier-Dequaire F; Sorbonne Universités, UMR_S1127, ICM, F-75013, Paris, France.
  • Bekadar S; INSERM, UMR_S1127, Paris, France.
  • Anheim M; CNRS, UMR_7225, Paris, France.
  • Lebbah S; Assistance Publique Hôpitaux de Paris, CHU Pitié-Salpêtrière, Department of Neurology, CIC-1422, NS-PARK/FCRIN network, Paris, France.
  • Pelissolo A; Sorbonne Universités, UMR_S1127, ICM, F-75013, Paris, France.
  • Krack P; INSERM, UMR_S1127, Paris, France.
  • Lacomblez L; CNRS, UMR_7225, Paris, France.
  • Lhommée E; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Castrioto A; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch, France.
  • Azulay JP; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.
  • Defebvre L; Assistance Publique Hôpitaux de Paris, Clinical Research Unit, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
  • Kreisler A; Assistance Publique Hôpitaux de Paris, Hôpitaux universitaires Henri-Mondor, DHU PePSY, Service de Psychiatrie; INSERM, U955, team 15; UPEC, Université Paris-Est, Faculté de Médecine, Créteil, France.
  • Durif F; Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France.
  • Marques-Raquel A; Grenoble Alpes University, Grenoble, France.
  • Brefel-Courbon C; Grenoble Institut des Neurosciences, INSERM U1216, Grenoble, France.
  • Grabli D; Department of Basic Neurosciences, Medical Faculty, University of Geneva, and Clinic of Neurology, Department of Clinical Neurosciences, Geneva University Hospital, Geneva, Switzerland.
  • Roze E; Sorbonne Universités, UMR_S1127, ICM, F-75013, Paris, France.
  • Llorca PM; Assistance Publique Hôpitaux de Paris, CHU Pitié-Salpêtrière, Department of Neurology, CIC-1422, NS-PARK/FCRIN network, Paris, France.
  • Ory-Magne F; Assistance Publique Hôpitaux de Paris, CHU Pitié-Salpêtrière, Service de Pharmacologie and Regional Pharmacovigilance Center, Paris, France.
  • Benatru I; Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France.
  • Ansquer S; Grenoble Alpes University, Grenoble, France.
  • Maltête D; Grenoble Institut des Neurosciences, INSERM U1216, Grenoble, France.
  • Tir M; Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France.
  • Krystkowiak P; Grenoble Alpes University, Grenoble, France.
  • Tranchant C; Grenoble Institut des Neurosciences, INSERM U1216, Grenoble, France.
  • Lagha-Boukbiza O; Assistance Publique Hôpitaux de Marseille, CHU Timone, Service de neurologie et pathologie du mouvement, Marseille, France; CNRS, institut de neurosciences de la Timone, Aix-Marseille université, UMR 7289, Marseille, France.
  • Lebrun-Vignes B; Université de Lille, faculté de médecine, CHRU de Lille, centre expert Parkinson, hôpital Salengro, service de neurologie et pathologie du mouvement, Lille, France.
  • Mangone G; INSERM, U 1171, NS-PARK/FCRIN Network, Lille, France.
  • Vidailhet M; Université de Lille, faculté de médecine, CHRU de Lille, centre expert Parkinson, hôpital Salengro, service de neurologie et pathologie du mouvement, Lille, France.
  • Charbonnier-Beaupel F; INSERM, UMR-S 1172; team "early stages of Parkinson's disease,", Lille, France.
  • Rascol O; Centre Hospitalo-Universitaire de Clermont-Ferrand, Department of Neurology, NS-PARK/FCRIN Network, Clermont-Ferrand, France.
  • Lesage S; Centre Hospitalo-Universitaire de Clermont-Ferrand, Department of Neurology, NS-PARK/FCRIN Network, Clermont-Ferrand, France.
  • Brice A; University of Toulouse 3, University Hospital of Toulouse, INSERM; Departments of Neurosciences and Clinical Pharmacology, Clinical Investigation Center CIC 1436, Toulouse Parkinson Expert Center, NS-Park/FCRIN Network and NeuroToul Center of Excellence for Neurodegenerative Disorders (COEN), Toulou
  • Tezenas du Montcel S; Sorbonne Universités, UMR_S1127, ICM, F-75013, Paris, France.
  • Corvol JC; INSERM, UMR_S1127, Paris, France.
Mov Disord ; 33(12): 1878-1886, 2018 12.
Article en En | MEDLINE | ID: mdl-30444952
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Levodopa / Receptores Opioides mu / Agonistas de Dopamina / Trastornos Disruptivos, del Control de Impulso y de la Conducta Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Levodopa / Receptores Opioides mu / Agonistas de Dopamina / Trastornos Disruptivos, del Control de Impulso y de la Conducta Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article